ArticleCureus2026
Bladder Urothelial Carcinoma Diagnosed by Perineal Cutaneous Biopsy: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bladder cancer is the most common malignancy of the urinary tract, and urothelial carcinoma represents its most frequent histological subtype in Brazil. Diagnosis is conventionally established by direct biopsy of the urothelial mucosa obtained through cystoscopy with transurethral resection of the bladder tumor, which also allows sampling of the detrusor muscle for adequate staging. We report the case of a 71-year-old hypertensive man without a smoking history who initially presented with perineal induration, difficulty in defecation, and intermittent diarrhea, and was first investigated for suspected inflammatory bowel disease. After an inconclusive colonoscopy, pelvic magnetic resonance imaging demonstrated bladder wall thickening with a right inferoposterior lesion measuring up to 3.7 cm, of probable neoplastic origin, extending toward the ureteral meatus, with bilateral upstream ureteropyelocaliceal dilation and contiguity with the prostate, corresponding to Vesical Imaging-Reporting and Data System (VI-RADS) category 5. On flexible ureteroscopy, the bladder lesion was directly visualized as a necrotic area consistent with tumor; transurethral resection could not be completed because perineal induration prevented advancement of the rigid instrument. Biopsies of the bladder and urethral mucosa were obtained with the flexible ureteroscope, together with an open incisional biopsy of the perineal skin. Histopathology of the bladder and urethral specimens showed only nonspecific chronic cystitis and urethritis, whereas the perineal skin specimen confirmed invasive urothelial carcinoma, with immunohistochemical positivity for GATA-binding protein 3 (GATA3) and cytokeratin 7 (CK7). The patient was later readmitted with postrenal acute kidney injury due to tumor invasion of the ureteral meatus, progressing to severe obstructive uropathy, and the disease had a fatal outcome despite bilateral nephrostomy and antibiotic therapy. This case illustrates cutaneous perineal biopsy as an unconventional but decisive diagnostic route when standard transurethral sampling is unfeasible or inconclusive.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.